VAGELOS P ROY - 03 Apr 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**P. Roy Vagelos
Issuer symbol
REGN
Transactions as of
03 Apr 2023
Net transactions value
$0
Form type
4
Filing time
05 Apr 2023, 16:02:23 UTC
Previous filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -259 -0.21% $0.000000 125,493 03 Apr 2023 by CLAT
holding REGN Common Stock 312,578 03 Apr 2023 Direct
holding REGN Common Stock 1,963 03 Apr 2023 By 401(k) Plan
holding REGN Common Stock 23,461 03 Apr 2023 by Spouse as Trustee
holding REGN Common Stock 3,609 03 Apr 2023 by trust for grandch F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.